Results
72
High return on equity, past performance and sound balance sheet.
72 companies
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹465.4b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,747.05
7D
0.4%
1Y
45.8%
Medpace Holdings
Market Cap: US$9.1b
Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.
MEDP
US$297.72
7D
3.7%
1Y
-24.6%
Novartis
Market Cap: CHF 163.4b
Engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.
NOVN
CHF 86.09
7D
-6.5%
1Y
-0.01%
Abbott India
Market Cap: ₹628.5b
Operates as a pharmaceutical company in India.
500488
₹29,578.60
7D
1.8%
1Y
11.8%
Protagonist Therapeutics
Market Cap: US$2.5b
A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.
PTGX
US$42.62
7D
-4.1%
1Y
57.6%
Xiamen Amoytop Biotech
Market Cap: CN¥31.2b
Engages in research, development, production, and sale of recombinant protein drugs in China.
688278
CN¥76.61
7D
-2.2%
1Y
21.2%
Torrent Pharmaceuticals
Market Cap: ₹1.1t
Engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.
500420
₹3,127.50
7D
-4.8%
1Y
21.4%
ChemoMetec
Market Cap: DKK 8.0b
Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
CHEMM
DKK 458.20
7D
7.8%
1Y
55.3%
Orion Oyj
Market Cap: €6.7b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€47.94
7D
-8.8%
1Y
45.3%
Blue Jet Healthcare
Market Cap: ₹118.6b
Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.
BLUEJET
₹683.55
7D
-5.9%
1Y
74.5%
Henan Lingrui Pharmaceutical
Market Cap: CN¥12.7b
Produces and sells medicines in China.
600285
CN¥22.63
7D
0.1%
1Y
2.0%
Exelixis
Market Cap: US$9.9b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$35.31
7D
2.1%
1Y
54.8%
Hunan Jiudian Pharmaceutical
Market Cap: CN¥8.3b
Researches, develops, produces, and sells pharmaceutical products in China and internationally.
300705
CN¥16.82
7D
-10.4%
1Y
-32.9%
Cosmo Pharmaceuticals
Market Cap: CHF 741.5m
Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
COPN
CHF 46.30
7D
-10.4%
1Y
-33.1%
Ajanta Pharma
Market Cap: ₹320.4b
A specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets speciality pharmaceutical finished dosages.
AJANTPHARM
₹2,565.40
7D
3.2%
1Y
21.3%
Jamjoom Pharmaceuticals Factory
Market Cap: ر.س10.4b
Manufactures and markets pharmaceutical products in the Kingdom of Saudi Arabia and internationally.
4015
ر.س151.80
7D
6.0%
1Y
15.0%
EZZ Life Science Holdings
Market Cap: AU$68.9m
Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally.
EZZ
AU$1.46
7D
0%
1Y
73.8%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥39.4b
Shanghai Allist Pharmaceuticals Co., Ltd.
688578
CN¥87.45
7D
-2.1%
1Y
89.2%
Agilent Technologies
Market Cap: US$29.3b
Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
A
US$102.71
7D
-0.3%
1Y
-27.0%
Imeik Technology DevelopmentLtd
Market Cap: CN¥55.2b
Engages in the research and development, production, and transformation of biomedical soft tissue repair materials in China.
300896
CN¥183.08
7D
1.1%
1Y
-11.6%
Mega Lifesciences
Market Cap: ฿24.0b
Manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods in Southeast Asia and Sub-Saharan Africa.
MEGA
฿27.50
7D
-6.8%
1Y
-32.9%
Consun Pharmaceutical Group
Market Cap: HK$7.8b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$9.36
7D
1.6%
1Y
63.1%
SKAN Group
Market Cap: CHF 1.4b
Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.
SKAN
CHF 61.10
7D
-1.5%
1Y
-25.7%
Chugai Pharmaceutical
Market Cap: JP¥10.3t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥6,286.00
7D
-5.5%
1Y
20.0%
Zhangzhou Pientzehuang Pharmaceutical
Market Cap: CN¥123.7b
Engages in the manufacture and sale of Chinese medicines under the Pien Tze Huang brand in China and internationally.
600436
CN¥205.00
7D
1.1%
1Y
-5.3%
Lotus Pharmaceutical
Market Cap: NT$56.3b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$212.00
7D
-8.6%
1Y
-38.0%
Caplin Point Laboratories
Market Cap: ₹142.1b
Engages in the development, production, marketing, and export of generic pharmaceutical formulations and branded products in India.
524742
₹1,869.40
7D
-3.5%
1Y
44.5%
hVIVO
Market Cap: UK£109.7m
Operates as a pharmaceutical service and contract research company in the United Kingdom.
HVO
UK£0.16
7D
11.2%
1Y
-44.0%
PeptiDream
Market Cap: JP¥241.5b
A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.
4587
JP¥1,863.00
7D
-3.9%
1Y
20.4%
Genmab
Market Cap: DKK 77.7b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GMAB
DKK 1,225.00
7D
-2.1%
1Y
-40.7%
Catalyst Pharmaceuticals
Market Cap: US$2.7b
A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.
CPRX
US$22.05
7D
-4.4%
1Y
44.9%
Tianjin Pharmaceutical Da Ren Tang Group
Market Cap: CN¥20.4b
Produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People’s Republic of China.
600329
CN¥30.38
7D
-3.4%
1Y
-3.8%
NATCO Pharma
Market Cap: ₹138.9b
A pharmaceutical company, engages in the developing, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally.
NATCOPHARM
₹775.50
7D
-2.7%
1Y
-20.4%
Sichuan Biokin PharmaceuticalLtd
Market Cap: CN¥97.9b
Engages in the research and development, production, and marketing of small molecule chemical, macromolecular biological, and antibody-drug conjugate drugs in China and internationally.
688506
CN¥244.20
7D
-2.4%
1Y
87.3%
Jagsonpal Pharmaceuticals
Market Cap: ₹14.0b
Engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally.
JAGSNPHARM
₹210.72
7D
-2.4%
1Y
79.5%
PharmaEngine
Market Cap: NT$12.1b
A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.
4162
NT$84.00
7D
-15.0%
1Y
-13.5%